Literature DB >> 17537011

Therapeutic effect of turquoise versus blue light with equal irradiance in preterm infants with jaundice.

Finn Ebbesen1, Poul Madsen, Søren Støvring, Heidi Hundborg, Giovanni Agati.   

Abstract

AIM: To compare the efficiency of turquoise light with that of TL52 blue in treatment of preterm infants with jaundice at the same level of body irradiance.
METHODS: Infants with gestational age 28-37 weeks and non-haemolytic hyperbilirubinemia were treated for 24 h with either turquoise light (OSRAM L18W/860 fluorescent lamps) or blue light (Philips TL20W/52 fluorescent lamps). The concentrations of serum total bilirubin and bilirubin isomers were measured by the Vitros routine method and by HPLC, respectively.
RESULTS: The decrease in serum concentrations of total bilirubin, total bilirubin isomers and the toxic Z,Z-bilirubin was greatest for infants treated with turquoise light. Further, the increase in Z,E-bilirubin was smaller and there was a trend towards a higher rise in E,Z-bilirubin.
CONCLUSIONS: Turquoise light has a greater bilirubin reducing effect than TL52 blue light with equal irradiance, expressed both by serum total bilirubin, total bilirubin isomers and Z,Z-bilirubin, i.e. the turquoise spectral range is more efficient than the blue. This is in accordance with deeper penetration into the skin, lower production of the Z,E-bilirubin and greater production of E,Z-bilirubin and lumirubin, in infants under turquoise light. This suggests, given equal irradiances, that light in the turquoise spectral range is preferable to the TL52 blue in treatment of newborn jaundiced infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537011     DOI: 10.1111/j.1651-2227.2007.00261.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Fluorescence excitation spectrum of bilirubin in blood: a model for the action spectrum for phototherapy of neonatal jaundice.

Authors:  Angelo A Lamola; Marie Russo
Journal:  Photochem Photobiol       Date:  2013-12-10       Impact factor: 3.421

2.  Early formation of bilirubin isomers during phototherapy for neonatal jaundice: effects of single vs. double fluorescent lamps vs. photodiodes.

Authors:  Khalaf Mreihil; Poul Madsen; Britt Nakstad; Jūratė Šaltytė Benth; Finn Ebbesen; Thor Willy Ruud Hansen
Journal:  Pediatr Res       Date:  2015-03-20       Impact factor: 3.756

Review 3.  Neonatal jaundice: phototherapy.

Authors:  Paul Woodgate; Luke Anthony Jardine
Journal:  BMJ Clin Evid       Date:  2015-05-22

4.  Effect of phototherapy with turquoise vs. blue LED light of equal irradiance in jaundiced neonates.

Authors:  Finn Ebbesen; Pernille K Vandborg; Poul H Madsen; Torleif Trydal; Lasse H Jakobsen; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2015-10-20       Impact factor: 3.756

5.  Double versus single intensive phototherapy with LEDs in treatment of neonatal hyperbilirubinemia.

Authors:  M L Donneborg; P K Vandborg; B M Hansen; M Rodrigo-Domingo; F Ebbesen
Journal:  J Perinatol       Date:  2017-11-02       Impact factor: 2.521

6.  The impact of hemoglobin on the efficacy of phototherapy in hyperbilirubinemic infants.

Authors:  Mette L Donneborg; Pernille K Vandborg; Bo M Hansen; Maria Rodrigo-Domingo; Finn Ebbesen
Journal:  Pediatr Res       Date:  2017-09-06       Impact factor: 3.756

Review 7.  Neonatal jaundice.

Authors:  Paul Woodgate; Luke Anthony Jardine
Journal:  BMJ Clin Evid       Date:  2011-09-15

8.  Action spectrum of phototherapy in hyperbilirubinemic neonates.

Authors:  Finn Ebbesen; Mette L Donneborg; Pernille K Vandborg; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2021-11-17       Impact factor: 3.953

9.  Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue).

Authors:  Finn Ebbesen; Poul H Madsen; Pernille K Vandborg; Lasse H Jakobsen; Torleif Trydal; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2016-05-25       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.